Article Details

PDL BioPharma (NASDAQ:PDLI) Upgraded to "Sell" at ValuEngine

Retrieved on: 2020-12-01 07:12:16

Tags for this article:

Click the tags to see associated articles and topics

PDL BioPharma (NASDAQ:PDLI) Upgraded to "Sell" at ValuEngine. View article details on hiswai:

Excerpt

Finally, TheStreet cut shares of PDL <b>BioPharma</b> from a "c-" rating to a "d+" rating in a research note on Wednesday, October 7th. Two investment ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up